Immunopharmacological potential of selective phosphodiesterase inhibition. II. Evidence for the involvement of an inhibitory-kappaB/nuclear factor-kappaB-sensitive pathway in alveolar epithelial cells.
about
Insights into the regulation of TNF-alpha production in human mononuclear cells: the effects of non-specific phosphodiesterase inhibitionExpression and localization of the multidrug resistance protein 5 (MRP5/ABCC5), a cellular export pump for cyclic nucleotides, in human heartScience review: Redox and oxygen-sensitive transcription factors in the regulation of oxidant-mediated lung injury: role for nuclear factor-kappaBOxygen-sensing mechanisms and the regulation of redox-responsive transcription factors in development and pathophysiologyA novel fluid resuscitation strategy modulates pulmonary transcription factor activation in a murine model of hemorrhagic shockThe dual phosphodiesterase 3 and 4 inhibitor RPL554 stimulates CFTR and ciliary beating in primary cultures of bronchial epithelia.Targeting inflammation to prevent bronchopulmonary dysplasia: can new insights be translated into therapies?Hesperidin-3'-o-methylether is more potent than hesperidin in phosphodiesterase inhibition and suppression of ovalbumin-induced airway hyperresponsiveness.Current perspectives on behavioural and cellular mechanisms of illness anorexia.Cyclic AMP: a selective modulator of NF-κB action.Treatment of endotoxaemia and septicaemia in the equine patient.Pentoxifylline attenuates the local and systemic inflammatory response after infrarenal abdominal aortic ischemia-reperfusion.Inhibitor kappa B-alpha (IkappaB-alpha) promoter polymorphisms in UK and Dutch sarcoidosis.Genotoxic, histologic, immunohistochemical, morphometric and hormonal effects of di-(2-ethylhexyl)-phthalate (DEHP) on reproductive systems in pre-pubertal male rats
P2860
Q24648587-57F6FDA1-27CE-4485-B191-78F85D122E07Q24685159-CA4593BB-321A-44EB-BDB5-EBFE49CF7297Q24791031-3F9510A1-D14E-402C-B5A3-AA6DE48BC906Q24802444-686367A9-8E5B-41F5-A0CE-43F869F34D9FQ33967835-EA8EC72E-C0D5-404A-AC06-59F570E1267DQ34500909-65F7F76F-1809-4FC5-9183-85B08F14A864Q35070866-E9B1F258-9A0A-4668-82E1-2A193A659764Q36311412-40494D32-145F-4521-B7A8-565C2B96777EQ36364190-DE9E68A1-45E5-493A-8DE8-35743E8BE732Q37899788-E00189EC-0CC4-499E-807E-E4C289850EDDQ38906880-BA16134E-329B-406A-A304-146451D14417Q46445099-A3A1687F-B990-407F-B03E-A2BFC449605AQ51656775-4B570CF8-9A0D-4AA6-B628-69925A00D64CQ57497585-C2ADBDDE-B21B-401B-A9F0-17CAF083087C
P2860
Immunopharmacological potential of selective phosphodiesterase inhibition. II. Evidence for the involvement of an inhibitory-kappaB/nuclear factor-kappaB-sensitive pathway in alveolar epithelial cells.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Immunopharmacological potentia ...... in alveolar epithelial cells.
@en
Immunopharmacological potentia ...... in alveolar epithelial cells.
@nl
type
label
Immunopharmacological potentia ...... in alveolar epithelial cells.
@en
Immunopharmacological potentia ...... in alveolar epithelial cells.
@nl
prefLabel
Immunopharmacological potentia ...... in alveolar epithelial cells.
@en
Immunopharmacological potentia ...... in alveolar epithelial cells.
@nl
P2093
P356
P1476
Immunopharmacological potentia ...... in alveolar epithelial cells.
@en
P2093
Danuta Kowalczyk
John J Haddad
Marek Zembala
Ryszard Lauterbach
William O Tarnow-Mordi
P304
P356
10.1124/JPET.300.2.567
P407
P577
2002-02-01T00:00:00Z